BME-Industry Grand Rounds, April 8: New Treatments for Epilepsy and Acute Anxiety

Robert K. Schultz and Ronald A. Siegel

Emergency in the Emergency Department
Robert Schultz, Ph.D., President and CEO, Sollievo Pharmaceuticals, Inc.

Intranasal Delivery of a Diazepam Prodrug for Rapid Reversal of Seizures
Ronald A. Siegel, Sc.D., Professor, Departments of Pharmaceutics and Biomedical Engineering, University of Minnesota


Start date
Monday, April 8, 2024, 3:35 p.m.
End date
Monday, April 8, 2024, 4:30 p.m.

Virtual event open to all